A prospective cohort-based artificial intelligence evaluation system for the protective efficacy and immune response of SARS-CoV-2 inactivated vaccines.
Zhang J, Meng Y, Yang M, Hao W, Liu J, Wu L, Yu X, Zhang Y, Lin B, Xie C, Ge L, Zhijie Zhang, Tong W, Chang Q, Liu Y, Zhang Y, Qin X.
Zhang J, et al. Among authors: wu l.
Int Immunopharmacol. 2024 May 10;134:112141. doi: 10.1016/j.intimp.2024.112141. Online ahead of print.
Int Immunopharmacol. 2024.
PMID: 38733819